Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [14858]

The appropriate use of Lu-177 PSMA-617 radionuclide therapy

The appropriate use of Lu-177 PSMA-617 radionuclide therapy

Global surge in cancers among the under 50s over past three decades

Global surge in cancers among the under 50s over past three decades

New insights into melanoma development and therapy

New insights into melanoma development and therapy

A free online tool can help prostate cancer patients save on out-of-pocket drug costs

A free online tool can help prostate cancer patients save on out-of-pocket drug costs

First-in-class targeted microRNA therapy slows cancer tumour growth

First-in-class targeted microRNA therapy slows cancer tumour growth

New genes and natural toxins offer hope for cancer patients unresponsive to chemotherapy

New genes and natural toxins offer hope for cancer patients unresponsive to chemotherapy

European Commission approves pembrolizumab plus trastuzumab and chemotherapy as first-line treatment for HER2-positive advanced gastric or gastroesophageal junction adenocarcinoma expressing PD-L1

European Commission approves pembrolizumab plus trastuzumab and chemotherapy as first-line treatment for HER2...

Stem cells used to target cancer treatment, protect heart cells

Stem cells used to target cancer treatment, protect heart cells

Intracellular recycling: the key to surviving potent anti-cancer drugs

Intracellular recycling: the key to surviving potent anti-cancer drugs

Why men, wealthy people and maritime residents are more likely to develop skin cancer

Why men, wealthy people and maritime residents are more likely to develop skin cancer

More from ecancer